Copyright Reports & Markets. All rights reserved.

Global Herceptin Biosimilar Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Herceptin Biosimilar Market Overview

      • 1.1 Product Overview and Scope of Herceptin Biosimilar
      • 1.2 Herceptin Biosimilar Segment by Type
        • 1.2.1 Global Herceptin Biosimilar Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Breast Cancer
        • 1.2.3 Colorectal Cancer
        • 1.2.4 Leukemia
        • 1.2.5 Lymphoma
        • 1.2.6 Other
      • 1.3 Herceptin Biosimilar Segment by Application
        • 1.3.1 Herceptin Biosimilar Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital & Clinics
        • 1.3.3 Oncology Centers
        • 1.3.4 Other
      • 1.4 Global Herceptin Biosimilar Market by Region
        • 1.4.1 Global Herceptin Biosimilar Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Herceptin Biosimilar Market Size
        • 1.5.1 Global Herceptin Biosimilar Revenue (2014-2025)
        • 1.5.2 Global Herceptin Biosimilar Production (2014-2025)

      2 Global Herceptin Biosimilar Market Competition by Manufacturers

      • 2.1 Global Herceptin Biosimilar Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Herceptin Biosimilar Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Herceptin Biosimilar Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Herceptin Biosimilar Production Sites, Area Served, Product Types
      • 2.5 Herceptin Biosimilar Market Competitive Situation and Trends
        • 2.5.1 Herceptin Biosimilar Market Concentration Rate
        • 2.5.2 Herceptin Biosimilar Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Herceptin Biosimilar Production Market Share by Regions

      • 3.1 Global Herceptin Biosimilar Production Market Share by Regions
      • 3.2 Global Herceptin Biosimilar Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Herceptin Biosimilar Production
        • 3.4.1 North America Herceptin Biosimilar Production Growth Rate (2014-2019)
        • 3.4.2 North America Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Herceptin Biosimilar Production
        • 3.5.1 Europe Herceptin Biosimilar Production Growth Rate (2014-2019)
        • 3.5.2 Europe Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Herceptin Biosimilar Production
        • 3.6.1 China Herceptin Biosimilar Production Growth Rate (2014-2019)
        • 3.6.2 China Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Herceptin Biosimilar Production
        • 3.7.1 Japan Herceptin Biosimilar Production Growth Rate (2014-2019)
        • 3.7.2 Japan Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Herceptin Biosimilar Consumption by Regions

      • 4.1 Global Herceptin Biosimilar Consumption by Regions
      • 4.2 North America Herceptin Biosimilar Consumption (2014-2019)
      • 4.3 Europe Herceptin Biosimilar Consumption (2014-2019)
      • 4.4 China Herceptin Biosimilar Consumption (2014-2019)
      • 4.5 Japan Herceptin Biosimilar Consumption (2014-2019)

      5 Global Herceptin Biosimilar Production, Revenue, Price Trend by Type

      • 5.1 Global Herceptin Biosimilar Production Market Share by Type (2014-2019)
      • 5.2 Global Herceptin Biosimilar Revenue Market Share by Type (2014-2019)
      • 5.3 Global Herceptin Biosimilar Price by Type (2014-2019)
      • 5.4 Global Herceptin Biosimilar Production Growth by Type (2014-2019)

      6 Global Herceptin Biosimilar Market Analysis by Applications

      • 6.1 Global Herceptin Biosimilar Consumption Market Share by Application (2014-2019)
      • 6.2 Global Herceptin Biosimilar Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Herceptin Biosimilar Business

      • 7.1 Amgen
        • 7.1.1 Amgen Herceptin Biosimilar Production Sites and Area Served
        • 7.1.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.1.3 Amgen Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 AryoGen Biopharma
        • 7.2.1 AryoGen Biopharma Herceptin Biosimilar Production Sites and Area Served
        • 7.2.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.2.3 AryoGen Biopharma Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Biocon
        • 7.3.1 Biocon Herceptin Biosimilar Production Sites and Area Served
        • 7.3.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.3.3 Biocon Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Celltrion
        • 7.4.1 Celltrion Herceptin Biosimilar Production Sites and Area Served
        • 7.4.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.4.3 Celltrion Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Gedeon Richter
        • 7.5.1 Gedeon Richter Herceptin Biosimilar Production Sites and Area Served
        • 7.5.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.5.3 Gedeon Richter Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Genor Biopharma
        • 7.6.1 Genor Biopharma Herceptin Biosimilar Production Sites and Area Served
        • 7.6.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.6.3 Genor Biopharma Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Mabion
        • 7.7.1 Mabion Herceptin Biosimilar Production Sites and Area Served
        • 7.7.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.7.3 Mabion Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.8 Mylan
        • 7.8.1 Mylan Herceptin Biosimilar Production Sites and Area Served
        • 7.8.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.8.3 Mylan Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Roche
        • 7.9.1 Roche Herceptin Biosimilar Production Sites and Area Served
        • 7.9.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.9.3 Roche Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 The Instituto Vital Brazil
        • 7.10.1 The Instituto Vital Brazil Herceptin Biosimilar Production Sites and Area Served
        • 7.10.2 Herceptin Biosimilar Product Introduction, Application and Specification
        • 7.10.3 The Instituto Vital Brazil Herceptin Biosimilar Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Herceptin Biosimilar Manufacturing Cost Analysis

      • 8.1 Herceptin Biosimilar Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Herceptin Biosimilar
      • 8.4 Herceptin Biosimilar Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Herceptin Biosimilar Distributors List
      • 9.3 Herceptin Biosimilar Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Herceptin Biosimilar Market Forecast

      • 11.1 Global Herceptin Biosimilar Production, Revenue Forecast
        • 11.1.1 Global Herceptin Biosimilar Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Herceptin Biosimilar Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Herceptin Biosimilar Price and Trend Forecast (2019-2025)
      • 11.2 Global Herceptin Biosimilar Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Herceptin Biosimilar Production, Revenue Forecast (2019-2025)
      • 11.3 Global Herceptin Biosimilar Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Herceptin Biosimilar Consumption Forecast (2019-2025)
        • 11.3.2 Europe Herceptin Biosimilar Consumption Forecast (2019-2025)
        • 11.3.3 China Herceptin Biosimilar Consumption Forecast (2019-2025)
        • 11.3.4 Japan Herceptin Biosimilar Consumption Forecast (2019-2025)
      • 11.4 Global Herceptin Biosimilar Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Herceptin Biosimilar Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        This report focuses on Herceptin Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Herceptin Biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Amgen
        AryoGen Biopharma
        Biocon
        Celltrion
        Gedeon Richter
        Genor Biopharma
        Mabion
        Mylan
        Roche
        The Instituto Vital Brazil

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Breast Cancer
        Colorectal Cancer
        Leukemia
        Lymphoma
        Other

        Segment by Application
        Hospital & Clinics
        Oncology Centers
        Other

        Buy now